Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Treasury Shares (2023 - 2024)

Corvus Pharmaceuticals (CRVS) has 2 years of Treasury Shares data on record, last reported at $400000.0 in Q3 2024.

  • For Q3 2024, Treasury Shares changed N/A year-over-year to $400000.0; the TTM value through Sep 2024 reached $400000.0, changed N/A, while the annual FY2023 figure was $400000.0, N/A changed from the prior year.
  • Treasury Shares reached $400000.0 in Q3 2024 per CRVS's latest filing, roughly flat from $400000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $400000.0 in Q4 2023 and bottomed at $400000.0 in Q4 2023.